Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Frontiers in Immunology
|
June 18, 2015
Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model
Claudia Carvalho-Queiroz, Ruth Nyakundi, Paul Ogongo, et al.
Frontiers in Immunology
|
October 29, 2020
Unbiased Profiling Reveals Compartmentalization of Unconventional T-Cells Within the Intestinal Mucosa Irrespective of HIV Infection
Magalli Magnoumba, Alveera Singh, Paul Ogongo, et al.
Frontiers in Immunology
|
July 24, 2019
Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children
Julia Roider, J Zachary Porterfield, Paul Ogongo, et al.
Infection and Immunity
|
December 6, 2021
Acquired Clinical Immunity to Malaria in Nonhuman Primates Coinfected with <i>Schistosoma</i> and <i>Plasmodium</i> Parasites
Ruth K Nyakundi, Jann Hau, Paul Ogongo, et al.
Frontiers in Immunology
|
November 30, 2018
Major TCR Repertoire Perturbation by Immunodominant HLA-B<sup>*</sup>44:03-Restricted CMV-Specific T Cells
Meriem Attaf, Amna Malik, Mai C Severinsen, et al.
Frontiers in Immunology
|
May 3, 2024
High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL-17 against <i>M. tuberculosis</i> antigen
Paul Ogongo, Anthony Tran, Florence Marzan, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL17 against <i>M. tuberculosis</i> antigen
Paul Ogongo, Anthony Tran, Florence Marzan, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
Immunopeptidomics informs discovery and delivery of <i>Mycobacterium tuberculosis</i> MHC-II antigens for vaccine design
Owen Leddy, Paul Ogongo, Julia Huffaker, et al.
Science Translational Medicine
|
November 5, 2025
Immunopeptidomics can inform the design of mRNA vaccines for the delivery of <i>Mycobacterium tuberculosis</i> MHC class II antigens
Owen Leddy, Paul Ogongo, Julia Huffaker, et al.
Frontiers in Immunology
|
December 17, 2021
A Framework to Identify Antigen-Expanded T Cell Receptor Clusters Within Complex Repertoires
Valentina Ceglia, Erin J Kelley, Annalee S Boyle, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Frontiers in Immunology
|
June 18, 2015
Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model
Claudia Carvalho-Queiroz, Ruth Nyakundi, Paul Ogongo, et al.
Frontiers in Immunology
|
October 29, 2020
Unbiased Profiling Reveals Compartmentalization of Unconventional T-Cells Within the Intestinal Mucosa Irrespective of HIV Infection
Magalli Magnoumba, Alveera Singh, Paul Ogongo, et al.
Frontiers in Immunology
|
July 24, 2019
Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children
Julia Roider, J Zachary Porterfield, Paul Ogongo, et al.
Infection and Immunity
|
December 6, 2021
Acquired Clinical Immunity to Malaria in Nonhuman Primates Coinfected with <i>Schistosoma</i> and <i>Plasmodium</i> Parasites
Ruth K Nyakundi, Jann Hau, Paul Ogongo, et al.
Frontiers in Immunology
|
November 30, 2018
Major TCR Repertoire Perturbation by Immunodominant HLA-B<sup>*</sup>44:03-Restricted CMV-Specific T Cells
Meriem Attaf, Amna Malik, Mai C Severinsen, et al.
Frontiers in Immunology
|
May 3, 2024
High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL-17 against <i>M. tuberculosis</i> antigen
Paul Ogongo, Anthony Tran, Florence Marzan, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL17 against <i>M. tuberculosis</i> antigen
Paul Ogongo, Anthony Tran, Florence Marzan, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
Immunopeptidomics informs discovery and delivery of <i>Mycobacterium tuberculosis</i> MHC-II antigens for vaccine design
Owen Leddy, Paul Ogongo, Julia Huffaker, et al.
Science Translational Medicine
|
November 5, 2025
Immunopeptidomics can inform the design of mRNA vaccines for the delivery of <i>Mycobacterium tuberculosis</i> MHC class II antigens
Owen Leddy, Paul Ogongo, Julia Huffaker, et al.
Frontiers in Immunology
|
December 17, 2021
A Framework to Identify Antigen-Expanded T Cell Receptor Clusters Within Complex Repertoires
Valentina Ceglia, Erin J Kelley, Annalee S Boyle, et al.
Page
of 4